LCP
SNY icon

Legacy Capital Partners’s Sanofi SNY Stock Holding History

Legacy Capital Partners’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,125
Closed -$305K – 119
2017
Q3 		$305K Sell
6,125
-600
-9% -$29K 0.16% 96
2017
Q2 		$322K Hold
6,725
– – 0.17% 93
2017
Q1 		$305K Buy
+6,725
New +$285K 0.17% 94

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Legacy Capital Partners's SNY Position: Q4 2017 in Review

Legacy Capital Partners sold out of Sanofi (SNY) in Q4 2017, closing a stake of 6,125 shares — an estimated $305K sold.

Legacy Capital Partners first reported a position in SNY in Q1 2017 and held it in 3 quarters. The position peaked at $322K in Q2 2017. 503 funds tracked by Wall St. Rank hold SNY as of Q4 2017.

  • Legacy Capital Partners reported no remaining Sanofi position as of Q4 2017 after selling out during the quarter.
  • Legacy Capital Partners sold 6,125 Sanofi shares in Q4 2017, an estimated $305K.
  • Legacy Capital Partners first reported a position in Sanofi in Q1 2017 and held it in 3 quarters.
  • Legacy Capital Partners's Sanofi position peaked at $322K in Q2 2017.
  • 503 funds tracked by Wall St. Rank held Sanofi as of Q4 2017.

Based on Legacy Capital Partners's 13F filing for Q4 2017, filed 7 Feb 2018.